WallStreetZenWallStreetZen

NYSE: MET
Metlife Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MET

Based on 9 analysts offering 12 month price targets for Metlife Inc

Min Forecast
$86.00+17.66%
Avg Forecast
$93.56+28%
Max Forecast
$99.00+35.45%

Should I buy or sell MET stock?

Based on 9 analysts offering ratings for Metlife Inc.

Strong Buy
Strong Buy
7 analysts 77.78%
Buy
1 analysts 11.11%
Hold
1 analysts 11.11%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MET's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MET as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MET stock forecasts and price targets.

MET stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-11
lockedlocked$00.00+00.00%2025-04-10
lockedlocked$00.00+00.00%2025-04-10
lockedlocked$00.00+00.00%2025-04-09
lockedlocked$00.00+00.00%2025-04-02Find Out Why
Piper Sandler
Top 8%
93
Strong BuyMaintains$94.00+28.61%2025-04-02Find out why
JP Morgan
Top 16%
85
Strong BuyMaintains$86.00+17.66%2025-04-02
BMO Capital
Bottom 29%
29
HoldInitiates Coverage On$97.00+32.71%2025-01-23
TD Cowen
Bottom 34%
34
Strong BuyMaintains$99.00+35.45%2024-11-27

1 of 1

Forecast return on equity

Is MET forecast to generate an efficient return?

Company
31.4%
Industry
23.5%
Market
81.63%
MET's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MET forecast to generate an efficient return on assets?

Company
1.27%
Industry
2.48%
MET is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MET earnings per share forecast

What is MET's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$9.11+52.27%
Avg 2 year Forecast
$10.27+71.81%
Avg 3 year Forecast
$11.31+89.19%
MET's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MET revenue forecast

What is MET's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$74.9B+5.57%
Avg 2 year Forecast
$78.1B+10.04%
Avg 3 year Forecast
$83.0B+16.96%
MET's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MET earnings growth forecast

How is MET forecast to perform vs Insurance - Life companies and vs the US market?

Company
23.83%
Industry
12.03%
Market
18.12%
MET's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MET's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MET's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MET revenue growth forecast

How is MET forecast to perform vs Insurance - Life companies and vs the US market?

Company
5.18%
Industry
2.41%
Market
10.33%
MET's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MET's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MET vs Property & Casualty Insurance Stocks

TickerPricePrice TargetUp/downsideConsensus
MET$73.09$93.56+28.00%Strong Buy
MFC$29.23$51.00+74.48%Buy
AFL$108.31$105.30-2.78%Hold
PRU$100.21$122.36+22.11%Hold
PUK$20.98N/AN/A
View Top Property & Casualty Insurance Stocks

Metlife Stock Forecast FAQ

Is Metlife Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: MET) stock is to Strong Buy MET stock.

Out of 9 analysts, 7 (77.78%) are recommending MET as a Strong Buy, 1 (11.11%) are recommending MET as a Buy, 1 (11.11%) are recommending MET as a Hold, 0 (0%) are recommending MET as a Sell, and 0 (0%) are recommending MET as a Strong Sell.

If you're new to stock investing, here's how to buy Metlife stock.

What is MET's earnings growth forecast for 2025-2027?

(NYSE: MET) Metlife's forecast annual earnings growth rate of 23.83% is forecast to beat the US Insurance - Life industry's average forecast earnings growth rate of 12.03%, and it is also forecast to beat the US market's average forecast earnings growth rate of 18.12%.

Metlife's earnings in 2025 is $4,226,000,000.On average, 7 Wall Street analysts forecast MET's earnings for 2025 to be $6,203,058,055, with the lowest MET earnings forecast at $5,960,745,245, and the highest MET earnings forecast at $6,539,789,069. On average, 7 Wall Street analysts forecast MET's earnings for 2026 to be $6,999,141,128, with the lowest MET earnings forecast at $6,812,280,280, and the highest MET earnings forecast at $7,255,078,498.

In 2027, MET is forecast to generate $7,706,937,049 in earnings, with the lowest earnings forecast at $7,595,692,512 and the highest earnings forecast at $7,895,432,845.

What is MET's revenue growth forecast for 2025-2027?

(NYSE: MET) Metlife's forecast annual revenue growth rate of 5.18% is forecast to beat the US Insurance - Life industry's average forecast revenue growth rate of 2.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.33%.

Metlife's revenue in 2025 is $70,986,000,000.On average, 5 Wall Street analysts forecast MET's revenue for 2025 to be $51,049,161,572,483, with the lowest MET revenue forecast at $49,723,344,684,741, and the highest MET revenue forecast at $52,725,686,911,144. On average, 5 Wall Street analysts forecast MET's revenue for 2026 to be $53,214,750,049,638, with the lowest MET revenue forecast at $51,669,020,492,353, and the highest MET revenue forecast at $55,184,920,092,224.

In 2027, MET is forecast to generate $56,556,887,453,951 in revenue, with the lowest revenue forecast at $55,847,677,303,473 and the highest revenue forecast at $57,800,154,491,716.

What is MET's forecast return on assets (ROA) for 2025-2028?

(NYSE: MET) forecast ROA is 1.27%, which is lower than the forecast US Insurance - Life industry average of 2.48%.

What is MET's Price Target?

According to 9 Wall Street analysts that have issued a 1 year MET price target, the average MET price target is $93.56, with the highest MET stock price forecast at $99.00 and the lowest MET stock price forecast at $86.00.

On average, Wall Street analysts predict that Metlife's share price could reach $93.56 by Apr 11, 2026. The average Metlife stock price prediction forecasts a potential upside of 28% from the current MET share price of $73.09.

What is MET's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: MET) Metlife's current Earnings Per Share (EPS) is $5.98. On average, analysts forecast that MET's EPS will be $9.11 for 2025, with the lowest EPS forecast at $8.75, and the highest EPS forecast at $9.60. On average, analysts forecast that MET's EPS will be $10.27 for 2026, with the lowest EPS forecast at $10.00, and the highest EPS forecast at $10.65. In 2027, MET's EPS is forecast to hit $11.31 (min: $11.15, max: $11.59).

What is MET's forecast return on equity (ROE) for 2025-2028?

(NYSE: MET) forecast ROE is 31.4%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.